Kisqali should always be used in combination with hormonal treatment that reduces the effect of oestrogen: either fulvestrant (which blocks oestrogen receptors) ...

Based on the observed QT prolongation during treatment, KISQALI may require dose interruption, reduction or discontinuation as described in Table 4 [see Dosage ...

Breast Cancer. Early breast cancer. Indicated in combination with an aromatase inhibitor for the adjuvant treatment of hormone receptor (HR)-positive, ...

Learn more about dosing of KISQALI® (ribociclib) in the treatment of HR+/HER2- metastatic breast cancer (mBC). See full Prescribing and Important Safety ...

KISQALI is taken with a hormone therapy. Hormone therapy is a type of medication that is used to add, block, or remove hormones. To understand how KISQALI works ...

Kisqali funciona bloqueando as proteínas chamadas quinases dependentes de ciclinas 4 e 6, que regulam o crescimento e a divisão das células. O bloqueio dessas ...

Sep 13, 2023 · If you have other questions about how Kisqali and Ibrance compare, talk with your doctor. They can help you find the best treatment for you.

The recommended dose is 600 mg (three 200-mg tablets) once daily for 21 days. After 21 days of treatment, you won't take Kisqali for 7 days.

Find answers to frequently asked questions about KISQALI for the treatment of metastatic breast cancer (mBC). See full Prescribing & Safety Information.

Be sure to tell your doctor about any liver problems you have before taking Kisqali. They'll recommend whether Kisqali is a treatment option for you. Cardiac ( ...